SuperScript IV First-Strand Synthesis System, Each and 3 more items

Life Technologies Corporation has been awarded a purchase order (A207_PO-0451543) by the University of Virginia for laboratory reagents and equipment totaling $1,641.60. The award, issued on June 23, 2026, encompasses four distinct line items to be delivered to Angela K Best-Campbell. The products include a SuperScript IV First-Strand Synthesis System ($636.65), an HBA1 Polyclonal Antibody ($381.00), RNase iZap RNase Decontamination Solution in 250 milliliter quantities ($84.53 each, two units ordered), and Isolectin GS-IB4 from Griffonia simplicifolia conjugated with Alexa Fluor 647 ($454.89).

The contract represents a procurement of molecular biology and laboratory research consumables by the University of Virginia, a Virginia-based institution. All deliverables are designated for receipt by the identified recipient at the contracting organization. The cumulative contract value of $1,641.60 reflects a single purchase order transaction rather than an ongoing requirements contract, with no separate annual value specified in the available documentation.